BIO-TECHNE CORP's ticker is TECH and the CUSIP is 09073M104. A total of 276 filers reported holding BIO-TECHNE CORP in Q2 2017. The put-call ratio across all filers is 0.25 and the average weighting 0.2%.
About BIO-TECHNE CORP
Bio-Techne Corp is a leading provider of innovative life science research tools and diagnostic solutions. The company is headquartered in Minneapolis, Minnesota, and has operations in over 50 countries worldwide. Bio-Techne's products and services are used by researchers and clinicians in a wide range of fields, including cancer research, stem cell research, and immunology.
Bio-Techne's success is due in large part to its commitment to innovation and customer service. The company invests heavily in research and development, and has a team of over 1,000 scientists working to develop new products and technologies. Bio-Techne also has a strong focus on customer service, with a dedicated team of technical support specialists available to assist customers with any questions or issues they may have.
In addition to its research tools and diagnostic solutions, Bio-Techne also has a growing portfolio of clinical diagnostic products. The company's Exosome Diagnostics subsidiary is a leader in the development of liquid biopsy tests for cancer diagnosis and monitoring.
Bio-Techne's leadership team is comprised of experienced executives with a track record of success in the life sciences industry. Charles Kummeth, the company's CEO, has been with Bio-Techne since 2013 and has overseen significant growth and expansion during his tenure.
Overall, Bio-Techne is a company with a strong reputation for innovation, customer service, and leadership in the life sciences industry. With a growing portfolio of products and services, the company is well-positioned for continued success in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $34,092 | -16.6% | 500 | 0.0% | 0.00% | 0.0% |
| Q2 2023 | $40,883 | +10.0% | 500 | 0.0% | 0.00% | 0.0% |
| Q1 2023 | $37,156 | +88366.7% | 500 | 0.0% | 0.00% | -25.0% |
| Q4 2022 | $42 | -99.9% | 500 | +300.0% | 0.00% | 0.0% |
| Q3 2022 | $36,000 | -16.3% | 125 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $43,000 | -20.4% | 125 | 0.0% | 0.00% | -20.0% |
| Q1 2022 | $54,000 | -16.9% | 125 | 0.0% | 0.01% | -16.7% |
| Q4 2021 | $65,000 | +6.6% | 125 | 0.0% | 0.01% | 0.0% |
| Q3 2021 | $61,000 | +8.9% | 125 | 0.0% | 0.01% | 0.0% |
| Q2 2021 | $56,000 | +16.7% | 125 | 0.0% | 0.01% | +20.0% |
| Q1 2021 | $48,000 | +26.3% | 125 | +3.3% | 0.01% | +25.0% |
| Q4 2020 | $38,000 | +26.7% | 121 | 0.0% | 0.00% | 0.0% |
| Q3 2020 | $30,000 | -6.2% | 121 | +0.8% | 0.00% | 0.0% |
| Q2 2020 | $32,000 | +39.1% | 120 | -0.8% | 0.00% | +33.3% |
| Q1 2020 | $23,000 | -11.5% | 121 | +0.8% | 0.00% | 0.0% |
| Q4 2019 | $26,000 | +8.3% | 120 | 0.0% | 0.00% | 0.0% |
| Q3 2019 | $24,000 | -4.0% | 120 | 0.0% | 0.00% | 0.0% |
| Q2 2019 | $25,000 | +8.7% | 120 | +0.8% | 0.00% | 0.0% |
| Q1 2019 | $23,000 | +15.0% | 119 | 0.0% | 0.00% | 0.0% |
| Q4 2018 | $20,000 | -9.1% | 119 | 0.0% | 0.00% | -25.0% |
| Q3 2018 | $22,000 | +22.2% | 119 | 0.0% | 0.00% | +33.3% |
| Q2 2018 | $18,000 | 0.0% | 119 | 0.0% | 0.00% | 0.0% |
| Q1 2018 | $18,000 | +5.9% | 119 | 0.0% | 0.00% | 0.0% |
| Q4 2017 | $17,000 | +21.4% | 119 | 0.0% | 0.00% | +50.0% |
| Q3 2017 | $14,000 | 0.0% | 119 | 0.0% | 0.00% | -33.3% |
| Q2 2017 | $14,000 | +16.7% | 119 | 0.0% | 0.00% | +50.0% |
| Q1 2017 | $12,000 | 0.0% | 119 | +0.8% | 0.00% | 0.0% |
| Q4 2016 | $12,000 | – | 118 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ROWLANDMILLER & PARTNERS.ADV | 47,975 | $3,701,751 | 0.85% |
| Diversified Trust Co | 13,882 | $1,071,135 | 0.04% |
| Czech National Bank | 27,698 | $2,137,178 | 0.03% |
| FULTON BANK, N.A. | 5,444 | $420,058 | 0.02% |
| DnB Asset Management AS | 27,637 | $2,132,471 | 0.01% |
| Versant Capital Management, Inc | 36 | $2,778 | 0.00% |
| MASSMUTUAL TRUST CO FSB/ADV | 371 | $28,626 | 0.00% |
| Bartlett & Co. LLC | 172 | $13 | 0.00% |